Subcutaneous tissue disorder
MONDO:0019296A disease involving the superficial fascia.
Also known as: disease of superficial fascia, disease or disorder of superficial fascia, disorder of superficial fascia, superficial fascia disease, superficial fascia disease or disorder
64 clinical trials for this condition and its sub-types, 0 tagged with Subcutaneous tissue disorder itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Subcutaneous tissue disorder
-
Lipedema 41 trials
-
Fibrodysplasia ossificans progressiva 10 trials
-
Cerebrotendinous xanthomatosis 6 trials
-
CLOVES syndrome 5 trials
-
Adiposis dolorosa 2 trials
-
Mycetoma 1 trial
-
FLOTCH syndrome 0 trials
-
Pierpont syndrome 0 trials
-
Roch-Leri mesosomatous lipomatosis 0 trials
-
Cytophagic histiocytic panniculitis 0 trials
-
Dissecting cellulitis of the scalp 0 trials
-
Encephalocraniocutaneous lipomatosis 0 trials
-
Familial angiolipomatosis 0 trials
-
Familial multiple lipomatosis 0 trials
-
Hemangioma of subcutaneous tissue 0 trials
-
Multiple symmetric lipomatosis 0 trials
1 sub-type
-
Nodular fasciitis 0 trials
2 sub-types
- Cranial nodular fasciitis 0 trials
- Intravascular fasciitis 0 trials
-
Experimental pill aims to stop extra bone growth in rare disease
Disease control Stopped earlyThis phase 2 trial tested two doses of an oral drug called fidrisertib (IPN60130) in children and adults with fibrodysplasia ossificans progressiva (FOP), a rare condition where soft tissues turn into bone. The goal was to see if the drug could reduce new abnormal bone growth com…
Phase 2 • Sponsor: Clementia Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Experimental cell therapy targets deadly childhood brain cancer
Disease control Stopped earlyThis early-phase trial tested a new immunotherapy approach for children with DIPG, a rare and aggressive brain stem tumor. After standard radiation and chemotherapy, patients received special vaccines and immune cells designed to attack the tumor. The study was small (11 particip…
Phase 1 • Sponsor: University of Florida • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC